Adverse Events during Dosing of Delayed-Release/Extended-Release Methylphenidate – Learnings from the Open-Label Phase of a Registration Trial and a Real-World Pharmacovigilance Program
Martin A. Katzman, BSc, MD, FRCPC; Victor Otcheretko, MD; Michelle D. Po, PhD; Cassandra L. Uchida, PhD; Bev Incledon, PhD
